Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.05 USD | -1.95% | +3.08% | +27.60% |
Apr. 19 | Lake Street Starts Cellebrite DI With Buy Rating, $13 Price Target | MT |
Apr. 01 | BofA Securities Adjusts Cellebrite DI Price Target to $13 From $12, Maintains Buy Rating | MT |
Financials (USD)
Sales 2024 * | 376M | Sales 2025 * | 445M | Capitalization | 2.27B |
---|---|---|---|---|---|
Net income 2024 * | 38M | Net income 2025 * | 51M | EV / Sales 2024 * | 5.24 x |
Net cash position 2024 * | 298M | Net cash position 2025 * | 426M | EV / Sales 2025 * | 4.14 x |
P/E ratio 2024 * |
69.4
x | P/E ratio 2025 * |
46.5
x | Employees | 1,008 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 44.13% |
Latest transcript on Cellebrite DI Ltd.
1 day | -1.95% | ||
1 week | +3.08% | ||
Current month | +2.22% | ||
1 month | +4.74% | ||
3 months | +19.07% | ||
6 months | +50.14% | ||
Current year | +27.60% |
Managers | Title | Age | Since |
---|---|---|---|
Yossi Carmil
CEO | Chief Executive Officer | 57 | 03-12-31 |
Dana Gerner
DFI | Director of Finance/CFO | 56 | 14-05-06 |
Ayala Shapira
CMP | Compliance Officer | 53 | 22-10-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Adam Clammer
BRD | Director/Board Member | 53 | 21-08-29 |
Thomas Hogan
CHM | Chairman | 64 | 23-08-07 |
Dafna Gruber
BRD | Director/Board Member | 58 | 21-08-29 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 0 M€ | +4.81% | - | |
0.00% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 11.05 | -1.95% | 554,607 |
24-05-09 | 11.27 | +1.81% | 465,254 |
24-05-08 | 11.07 | -1.77% | 483,000 |
24-05-07 | 11.27 | +0.63% | 549,017 |
24-05-06 | 11.2 | +4.48% | 590,154 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.60% | 2.27B | |
+10.29% | 3,082B | |
+8.12% | 84.92B | |
+5.55% | 78.23B | |
-13.69% | 54.06B | |
-24.43% | 46.79B | |
+19.98% | 45.87B | |
+21.26% | 42.68B | |
+60.27% | 37.28B | |
-9.36% | 24.89B |
- Stock Market
- Equities
- CLBT Stock